摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-4-trifluoromethyl-5-pyridineboronic acid | 1045861-32-2

中文名称
——
中文别名
——
英文名称
2-amino-4-trifluoromethyl-5-pyridineboronic acid
英文别名
(6-Amino-4-(trifluoromethyl)pyridin-3-yl)boronic acid;[6-amino-4-(trifluoromethyl)pyridin-3-yl]boronic acid
2-amino-4-trifluoromethyl-5-pyridineboronic acid化学式
CAS
1045861-32-2
化学式
C6H6BF3N2O2
mdl
——
分子量
205.932
InChiKey
BFGHJUHRLUFXHE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    391.8±52.0 °C(Predicted)
  • 密度:
    1.51±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.64
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    79.4
  • 氢给体数:
    3
  • 氢受体数:
    7

安全信息

  • 海关编码:
    2933399090

反应信息

  • 作为反应物:
    描述:
    2-amino-4-trifluoromethyl-5-pyridineboronic acid 、 3-(6-bromo-4-chloroquinolin-3-yl)acrylate 、 间氨基三氟甲苯盐酸potassium phosphate四(三苯基膦)钯 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺异丙醇 为溶剂, 反应 0.42h, 生成 9-(6-amino-4-(trifluoromethyl)pyridin-3-yl)-1-(3(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one
    参考文献:
    名称:
    1,9取代的苯并[ h ] [1,6]萘啶-2(1 H)-酮的高效合成及其对恶性疟原虫的杀细胞活性的评价
    摘要:
    为合成苯并[ h ] [1,6]萘啶-2(1 H),开发了一种新颖的三组分,两步,一锅亲核芳香取代(S N Ar)-分子内环化-Suzuki偶联反应。-一个(Torins)。在新的有效收敛的合成路线的基础上,合成了都灵类似物的文库。使用生长抑制测定法评估这些化合物对无性寄生虫的抗疟活性,并使用生存力测定法评估配子细胞。
    DOI:
    10.1021/acscombsci.7b00119
  • 作为产物:
    参考文献:
    名称:
    Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
    摘要:
    Phosphoinositide-3-kinases (PI3Ks) are important oncology targets due to the deregulation of this signaling pathway in a wide variety of human cancers. Herein we describe the structure guided optimization of a series of 2-morpholino, 4-substituted, 6-heterocydic pyrirnidines where the pharmacokinetic properties were improved by modulating the electronics of the 6-position heterocycle, and the overall druglike properties were fine-tuned further by modification of the 4-position substituent. The resulting 2,4-bismorpholino 6-heterocyclic pyrirnidines are potent class I PI3K inhibitors showing mechanism modulation in PI3K dependent cell lines and in vivo efficacy in tumor xenograft models with PI3K pathway deregulation (A2780 ovarian and U87MG glioma). These efforts culminated in the discovery of 15 (NVP-BKM120), currently in Phase II clinical trials for the treatment of cancer.
    DOI:
    10.1021/ml200156t
点击查看最新优质反应信息

文献信息

  • Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer
    作者:Matthew T. Burger、Sabina Pecchi、Allan Wagman、Zhi-Jie Ni、Mark Knapp、Thomas Hendrickson、Gordana Atallah、Keith Pfister、Yanchen Zhang、Sarah Bartulis、Kelly Frazier、Simon Ng、Aaron Smith、Joelle Verhagen、Joshua Haznedar、Kay Huh、Ed Iwanowicz、Xiaohua Xin、Daniel Menezes、Hanne Merritt、Isabelle Lee、Marion Wiesmann、Susan Kaufman、Kenneth Crawford、Michael Chin、Dirksen Bussiere、Kevin Shoemaker、Isabel Zaror、Sauveur-Michel Maira、Charles F. Voliva
    DOI:10.1021/ml200156t
    日期:2011.10.13
    Phosphoinositide-3-kinases (PI3Ks) are important oncology targets due to the deregulation of this signaling pathway in a wide variety of human cancers. Herein we describe the structure guided optimization of a series of 2-morpholino, 4-substituted, 6-heterocydic pyrirnidines where the pharmacokinetic properties were improved by modulating the electronics of the 6-position heterocycle, and the overall druglike properties were fine-tuned further by modification of the 4-position substituent. The resulting 2,4-bismorpholino 6-heterocyclic pyrirnidines are potent class I PI3K inhibitors showing mechanism modulation in PI3K dependent cell lines and in vivo efficacy in tumor xenograft models with PI3K pathway deregulation (A2780 ovarian and U87MG glioma). These efforts culminated in the discovery of 15 (NVP-BKM120), currently in Phase II clinical trials for the treatment of cancer.
  • Efficient Synthesis of 1,9-Substituted Benzo[<i>h</i>][1,6]naphthyridin-2(1<i>H</i>)-ones and Evaluation of their <i>Plasmodium falciparum</i> Gametocytocidal Activities
    作者:Hao Li、Wei Sun、Xiuli Huang、Xiao Lu、Paresma R. Patel、Myunghoon Kim、Meghan J. Orr、Richard M. Fisher、Takeshi Q Tanaka、John C. McKew、Anton Simeonov、Philip E. Sanderson、Wei Zheng、Kim C. Williamson、Wenwei Huang
    DOI:10.1021/acscombsci.7b00119
    日期:2017.12.11
    A novel three-component, two-step, one-pot nucleophilic aromatic substitution (SNAr)–intramolecular cyclization–Suzuki coupling reaction was developed for the synthesis of benzo[h][1,6]naphthyridin-2(1H)-ones (Torins). On the basis of the new efficiently convergent synthetic route, a library of Torin analogs was synthesized. The antimalarial activities of these compounds were evaluated against asexual
    为合成苯并[ h ] [1,6]萘啶-2(1 H),开发了一种新颖的三组分,两步,一锅亲核芳香取代(S N Ar)-分子内环化-Suzuki偶联反应。-一个(Torins)。在新的有效收敛的合成路线的基础上,合成了都灵类似物的文库。使用生长抑制测定法评估这些化合物对无性寄生虫的抗疟活性,并使用生存力测定法评估配子细胞。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-